US futures are trading higher this morning, up 0.78% for the S&P 500, as investors weight the Pfizer vaccine news and the expected recovery in the US economy versus the record high Covid-19 cases nationwide and expected lockdowns in Western Europe and expectations for more near term economy turmoil. EU markets are marginally higher and trading a lackluster narrow range session, up 0.25% for the leading EURSXX50 index while Asian markets closed mostly in the red, led by a 1.05% drop in the CSI 300. FX markets are trading a narrow range session as well, with very little market moving news on the agenda, the dollar index is at 92.87 this morning, down 0.15% and trading just above 2020 lows. Gold and Silver are sea sowing near the flat line as well, Gold trades higher by 0.32% at $1,879 per ounce while Silver is up 0.15%, trading at $24.14 per ounce. Oil prices are lower after the early week surge, trading down nearly 1.5% at the $40.44 level as investors fear more coronavirus shutdowns and lower traffic into the upcoming holiday season. Weekly inventories numbers increased by 4.3 million barrels, versus a drop of nearly one million expected by the API, further adding pressure on prices near term.

US Core PPI at 8:30 am and US Consumer Sentiment at 10:00 am are the important news on the agenda Friday, (all times EST).

Global Markets 24 hours wrap-up
1 YEAR-1.43%-14.24%
Swing report
EURUSD186915506/111814stopped out
OIL40.651035013/1142new position
OPEN PROFIT  $350   

The NASDAQ 100 and S&P 500 futures are higher this morning, as investors optimism grows following the successful Covid-19 Pfizer vaccine trial.

Oil investors are in profit taking mood this morning as Covid-19 record numbers sweep the US and EU and following the 9% rally in Oil prices this week.

Warning: The information provided on this page (“the information”) is for instructional purposes only, for enhancing your general knowledge of the capital market in general and using trading methods and the technical analysis method in particular. We hereby clarify that the company, its management, staff, shareholders and agents do not hold investment advisor licenses and/or portfolio manager licenses by any applicable law, and do not pretend to advise any person on the worthiness of buying, selling, holding or investing in securities and other financial assets. The information should not be construed to be a recommendation or opinion, and any person who makes any decision based on the information – does so entirely at their own risk. Be aware that the information cannot serve in lieu of advice which accounts for specific information and needs of an individual, and that investing in securities and financial assets may cause loss. The company, its management, staff and agents may have a personal interest in issues related to the information, and may hold specific securities mentioned in the information, or similar securities. If you use the information, you waive any claim or demand against the company or anyone acting on its behalf.